To prevent the development of retinopathy, it is necessary to regularly visit an ophthalmologist!

The most dangerous manifestation of diabetes is retinal damage (diabetic retinopathy), which, due to a cascade of subsequent pathological processes, can lead to vision loss. Difficulties in timely diagnosis and treatment are related to the fact that visual acuity does not always reflect the severity of the process in the fundus—even in advanced stages of the disease, high visual function may be preserved. Unfortunately, patients seek medical attention when severe changes (hemorrhages, tractional retinal detachment) occur, i.e., at a stage of the disease when urgent surgical treatment is indicated to restore vision. Therefore, it is so important for patients with diabetes to be regularly monitored by a laser surgeon.
Today, timely panretinal laser photocoagulation is a generally accepted treatment for diabetic eye disease, proven effective in multicenter clinical trials. According to the World Health Organization Study Group, early detection and laser treatment preserve vision and prevent further disease progression in approximately 70% of cases. Our center utilizes state-of-the-art equipment, allowing for gentle laser interventions, energy-saving procedures, and laser burn technology, ensuring maximum patient comfort.
Panretinal laser coagulation of the retina is performed in 2-3 sessions, with an interval of at least 2-3 weeks between sessions for each eye. This allows the subsequent stage of laser photocoagulation to be performed after complete regression of even subclinical reactive edema resulting from laser burns, causing minimal trauma to the microstructure of the chorioretinal complex.
At our center, we perform laser treatment even in the most severe cases. Our many years of experience prove that timely and adequate panretinal laser photocoagulation can achieve good results even in this group of patients. It has also been proven that if laser coagulation is ineffective as a standalone treatment, further therapy is more effective in patients who have previously undergone panretinal laser coagulation.
In cases of severe diabetic macular edema, or if hemorrhagic activity of newly formed vessels in the fundus persists, intravitreal angiogenesis inhibitors are administered: Lucentis and Elia (EYLEA). The standard technique initially involves three mandatory sequential monthly injections. The number of subsequent injections and the interval between them are prescribed by the physician, based on objective data and the results of optical coherence tomography.
У цэнтры мікрахірургіі вока VOKA у Гродне вы можаце атрымаць кансультацыю кваліфікаваных урачоў-афтальмолагаў, прайсці абследаванне ў тым ліку, з прымяненнем аптычнай кагерэнтнай тамаграфіі (адзін з найбольш дакладных і ўніверсальных метадаў марфалагічнага даследавання ў афтальмалогіі).
29 640 77 00